Certified by Founder Lodge
Samsara BioCapital
United States - Palo Alto, California
INVESTOR
1 Disclosed Funding Rounds $90,000,000
13 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
N/A
| Company | Date | Round | Raised |
|---|---|---|---|
 SpyGlass Pharma, Inc. |
July, 11 ,2023 | Series C | $90,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 Seismic Therapeutic |
December, 05 ,2023 | Series B | $121,000,000 |
 FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
 Alumis |
March, 07 ,2024 | Series C | $259,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
 Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
 A2 Biotherapeutics, Inc. |
January, 10 ,2025 | Series C | $80,000,000 |
 Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
